Trinity Biotech plc

(TRIB) Trade

By |

Profile

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment.

Contact Information

Website: www.trinitybiotech.com
Email: kevin.tansley@trinitybiotech.com
Main Phone: +353 12769800
Address: IDA Business Park
Address 2: Bray, Co. Wicklow
City / Town: Dublin
Country: IRL

Issuer Information

Exchange: NGS
CEO: Ronan O'Caoimh
Employees: 575
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)


Gathering Data... Please wait

Profile

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment.

Contact Information

Website: www.trinitybiotech.com
Email: kevin.tansley@trinitybiotech.com
Main Phone: +353 12769800
Address: IDA Business Park
Address 2: Bray, Co. Wicklow
City / Town: Dublin
Country: IRL

Issuer Information

Exchange: NGS
CEO: Ronan O'Caoimh
Employees: 575
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 2.20 $ -0.11 (-4.76%)
Last Price 2.20 Change $ -0.11 Change % -4.76 Tick N/A
Bid 1.40 Bid Size 100.00 Ask 2.95 Ask Size 2,900.00
Open 2.30 High 2.39 Low 2.20 Prev Close 2.31
Last Trade Volume 11,857 52 Wk Hi 5.20 52 Wk Low 1.57
Market Cap 46 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,901,602.00 EPS (TTM) -1.07 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 7 7 7 7
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/08/18 03/08/18 03/08/18 03/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2